Login to Your Account

Patient Portal & Services Help Shire Launch HAE Drug Firazyr

By Mari Serebrov

Friday, August 26, 2011
Shire Human Genetic Therapies (HGT) is getting social as it launches its newly approved Firazyr, a self-administered injectable treatment for acute attacks of hereditary angioedema (HAE) in adults.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription